Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Microsoft Pivots Copilot From Free Bundle to Paid Product — And Says It Hit ‘Audacious’ Q1 Sales Goals

by Team Lumida
10 hours ago
The AI Investment Dilemma: Future-Proof or Financial Folly?

Microsoft has shifted its AI sales strategy from giving Copilot away free to aggressively selling it as a paid subscription — and says it essentially hit 'audacious' internal...

Read more

Amazon Hits Third-Party Sellers With 3.5% Fuel Surcharge as Iran War Pushes Logistics Costs Higher

by Team Lumida
4 days ago
Amazon Targets Rural America: A Game-Changer for Delivery Services

Amazon will impose a temporary 3.5% fuel surcharge on sellers using its Fulfillment by Amazon service starting April 17, joining UPS, FedEx, and a first-ever USPS fuel surcharge...

Read more

SpaceX Confidentially Files for IPO — Could Be the Largest Stock Offering in History

by Team Lumida
4 days ago
SpaceX Confidentially Files for IPO — Could Be the Largest Stock Offering in History

SpaceX has filed confidential IPO paperwork with the SEC targeting a raise of $40 billion to $80 billion — what could be the largest initial public offering ever...

Read more

Nike CEO Tells Staff He’s Tired of ‘Fixing’ the Business as Turnaround Stalls

by Team Lumida
4 days ago
white and black concrete building

After Nike issued a deeply disappointing forward outlook sending shares to a 12-year low, CEO Elliott Hill held an internal all-hands where he admitted parts of his strategy...

Read more

Record 22 Mega-Deals in Q1 2026 — The Strongest Start for Big Corporate Deals in History

by Team Lumida
6 days ago
AI Job-Loss Panic Is Running Ahead of the Data, Says Bloomberg Opinion

Q1 2026 shattered the all-time record for mega-deals with 22 transactions above $10 billion globally, the strongest quarterly start ever, even as the Iran war rattled markets and...

Read more

Nike Shares Tumble as Iran War and Global Discounting Cloud Turnaround Outlook

by Team Lumida
6 days ago
white and black concrete building

Nike issued a surprisingly gloomy outlook — revenue expected to fall 2-4% this quarter — as the Iran war disrupts EMEA traffic, China discounting intensifies, and CEO Elliott...

Read more

Goldman Stands Firm on $5,400 Gold Target Even as Iran War Selloff Deepens

by Team Lumida
7 days ago
Goldman Sachs Urges Investors to Cut Risk: Is a Selloff Looming?

Goldman Sachs is holding its $5,400 year-end gold target despite a 13% Iran war selloff, arguing the drop has overshot by focusing too much on inflation rather than...

Read more

McCormick to Buy Unilever’s $15.7B Food Empire in a Deal That Reshapes the Global Pantry

by Team Lumida
7 days ago
McCormick to Buy Unilever’s $15.7B Food Empire in a Deal That Reshapes the Global Pantry

McCormick is buying most of Unilever's food division — including Hellmann's, Knorr, and Marmite — for $15.7 billion in cash plus McCormick equity, in one of the largest...

Read more

Wall Street Just Wrapped Its Worst Quarter in Four Years — and Investors Are Bracing for Worse

by Team Lumida
7 days ago
AI Job-Loss Panic Is Running Ahead of the Data, Says Bloomberg Opinion

U.S. stocks are closing Q1 2026 in their worst quarter in four years: the Nasdaq and Dow both entered correction territory, 10 of 11 S&P sectors fell an...

Read more

Global Bond Rally Signals Market Is Now More Afraid of Recession Than Inflation

by Team Lumida
1 week ago
Risk-Off Wave Hits Everything: Tech, Crypto, and Metals Unwind as Valuation Anxiety Spreads

Global sovereign bonds rallied Monday as investors shifted from pricing an oil-shock inflation surge to pricing a war-driven growth slowdown — with Goldman at 30% recession odds, Pimco...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

U.S. Struggles to Break China’s Grip on Critical Minerals as Syrah Resources Faces Setbacks

China Quietly Signals Banks to Reduce US Treasury Exposure

February 9, 2026
The Procter & Gamble Company (PG) Q2 2025 Earnings

The Procter & Gamble Company (PG) Q2 2025 Earnings

January 23, 2025
Microsoft’s AI Ambitions: A Costly Path Forward

Microsoft Tries to Catch Up in AI With Healthcare Push, Harvard Deal

October 9, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018